Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.

Clinical trial NCT01476046 · COMPLETED

Trial details

NCT number: NCT01476046
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Disorders

Start date: 2011-03-08
Primary completion: 2012-06-17
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.